Thursday, 21 Jul 2022 | Funding Deadline
This scheme provides funding for biomarker assay development, validation and qualification where there is a clear line of sight to clinical implementation. This scheme accepts applications for biomarker assay development, validation and qualification where there is a clear line of sight to clinical implementation. All types of biomarkers will be considered, including predisposition, screening, diagnostic, prognostic, predictive, pharmacological and surrogate response markers. Proposals can use invasive or imaging techniques. Biosamples or images can be collected as part of the proposal or accessed from existing sample/data sets.
Deadline for proposals: 21 July 2022
Find out more here